Escherichia coli O157:H7

被引:491
作者
Mead, PS [1 ]
Griffin, PM [1 ]
机构
[1] Ctr Dis Control & Prevent, Foodborne & Diarrheal Dis Branch, Atlanta, GA 30333 USA
关键词
D O I
10.1016/S0140-6736(98)01267-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Escherichia coli O157 was first identified as a human pathogen in 1982. One of several Shiga toxin-producing serotypes known to cause human illness, the organism probably evolved through horizontal acquisition of genes for Shiga toxins and other virulence factors. E coli O157 is found regularly in the faeces of healthy cattle, and is transmitted to humans through contaminated food, water, and direct contact with infected people or animals. Human infection is associated with a wide range of clinical illness, including asymptomatic shedding, non-bloody diarrhoea, haemorrhagic colitis, haemolytic uraemic syndrome, and death. Since laboratory practices vary, physicians need to know whether laboratories in their area routinely test for E coli O157 in stool specimens. Treatment with antimicrobial agents remains controversial: some studies suggest that treatment may precipitate haemolytic uraemic syndrome, and other studies suggest no effect or even a protective effect. Physicians can help to prevent E coli O157 infections by counselling patients about the hazards of consuming undercooked ground meat or unpasteurised milk products and juices, and about the importance of handwashing to prevent the spread of diarrhoeal illness, and by informing public health authorities when they see unusual numbers of cases of bloody diarrhoea or haemolytic uraemic syndrome.
引用
收藏
页码:1207 / 1212
页数:6
相关论文
共 88 条
[72]   SEQUELAE OF HEMOLYTIC UREMIC SYNDROME [J].
SCHLIEPER, A ;
ROWE, PC ;
ORRBINE, E ;
ZOUBEK, M ;
CLARK, W ;
WOLFISH, N ;
MCLAINE, PN .
ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (07) :930-934
[73]   Analysis of the EHEC hly operon and its location in the physical map of the large plasmid of enterohaemorrhagic Escherichia coli O157:H7 [J].
Schmidt, H ;
Kernbach, C ;
Karch, H .
MICROBIOLOGY-UK, 1996, 142 :907-914
[74]  
Siegler RL, 1995, PEDIATR CLIN N AM, V42, P1505
[75]   Escherichia coli O157:H7 diarrhea in the United States: Clinical and epidemiologic features [J].
Slutsker, L ;
Ries, AA ;
Greene, KD ;
Wells, JG ;
Hutwagner, L ;
Griffin, PM .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (07) :505-+
[76]   Duration of faecal shedding of Escherichia coli O157:H7 among children in day-care centres [J].
Swerdlow, DL ;
Griffin, PM .
LANCET, 1997, 349 (9054) :745-746
[77]  
Takeda T, 1998, ESCHERICHIA COLI O15, P385
[78]   LESSONS LEARNED IN THE MANAGEMENT OF HEMOLYTIC-UREMIC SYNDROME IN CHILDREN [J].
TAPPER, D ;
TARR, P ;
AVNER, E ;
BRANDT, J ;
WALDHAUSEN, J .
JOURNAL OF PEDIATRIC SURGERY, 1995, 30 (02) :158-163
[79]   Perspective: The problem of non-O157:H7 shiga toxin (verocytotoxin)-producing Escherichia coli [J].
Tarr, PI ;
Neill, MA .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :1136-1139
[80]   ESCHERICHIA-COLI O157-H7 - CLINICAL, DIAGNOSTIC, AND EPIDEMIOLOGIC ASPECTS OF HUMAN INFECTION [J].
TARR, PI .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (01) :1-10